Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | APG-5918 |
| Synonyms | |
| Therapy Description |
APG-5918 (EEDi-5273) inhibits EED, potentially resulting in decreased tumor growth (PMID: 34613724). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| APG-5918 | APG 5918|APG5918|EEDi-5273|EEDi5273|EEDi 5273 | APG-5918 (EEDi-5273) inhibits EED, potentially resulting in decreased tumor growth (PMID: 34613724). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT05415098 | Phase I | APG-5918 | Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or Lymphomas | Unknown status | USA | 0 |